LKFT - Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV

LKFT
⚕️ Healthcare NASDAQ Listed 2015 € EUR
$1,000 invested 10 years ago →$481today

Score Overview

1 Year
Score
Net Growth85.93%
Net TrendGrew
Net Income Consistency—
Rev Growth-10.94%
Rev TrendShrank
Revenue Consistency—
5 Years
Score7.3
Net Growth7x
Net Trend60%
Net Income Consistency—
Rev Growth322.63%
Rev Trend60%
Revenue Consistency—
All Time
Score
Net Growth7x
Net Trend60%
Net Income Consistency
Rev Growth322.63%
Rev Trend60%
Revenue Consistency

Explore the 2021 public Archive ranking →

Where Lakefront Biotherapeutics NV has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. LKFT does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-23
$ 31.65—
1 Year2025-10-23
$ 32.03-1.19%
5 Years2021-10-22
$ 50.93-37.86%
10 Years2016-10-21
$ 65.74-51.86%
All Time2015-05-14
$ 50.50-37.33%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in EUR

Year
TTM€ 990M€ 596M€ 2.23B
2025€ 1.11B€ 320M€ 2.99B
2024€ 275M€ 74M
2023€ 239M€ 211M
2022€ 241M-€ 217M
2021€ 234M-€ 103M
LKFT - Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV fundamental performance

Between 2021 and 2025, revenue grew from € 234M to € 1.11B and net income went from -€ 103M to € 320M. Revenue increased in 60% of the years measured; net income in 60%.

Lakefront Biotherapeutics NV currently holds a 5-year HDB Score of 7.3 out of 10. How the HDB Score is calculated.

Membership

Explore LKFT with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,112 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year · Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies